12 related news articles for Signal Transduction in Cancer Biology
-
Defeating lung cancer
Associate Professor Dan Gough and his team have developed sophisticated models of lung cancer which allow them to model disease progression and observe response to current treatments in patients.… Read more
-
PASO Fellowship cements Hudson’s lung cancer leadership
Associate Professor Daniel Gough has received the first ever PASO Fellowship at Hudson Institute, securing the future of his ground-breaking lung cancer research.… Read more
-
How cancer works – a decade’s research unlocks secrets
Ten years of research has revealed a vital secret to how cancer cells work, and opened the door to potential new treatments.… Read more
-
2023 Science Innovation Seed Funding Awards
Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.… Read more
-
New treatment promises to increase lung cancer survival
Researchers at Hudson Institute of Medical Research have shown a new drug that is incredibly effective in treating small cell lung cancer – doubling the usual survival time.… Read more
-
Combatting a killer – understanding what causes small cell lung cancer
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.… Read more
-
Key to immune system inflammation discovery
Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.… Read more
-
Congratulations to our CASS Foundation grant awardees
Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.… Read more
-
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
-
Shedding light on the male bias in childhood brain tumours
Hudson Institute researchers discover why the most common form of childhood brain cancer is seen in boys more than girls, and identify a potential biomarker for less aggressive treatment.… Read more
-
Hudson Institute joins international paediatric cancer consortium
Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and… Read more
-
VCA funding for Hudson Institute researchers
MIMR-PHI cancer researchers, Drs George Grigoriadis and Daniel Gough were among 25 scientists recently awarded VCA funding.… Read more